The available info (inc.your "evidence") suggests that the odds of the below are much more favorable to AMRN (90+%) than you believe:
-sNDA approval -no AC meeting -no clinical hold on EVAPORATE -no extension of PDUFA date -settlement of patent litigation cases or win in patent litigations (February / March)